GSK vs SNTI · P/E 13, $103.31B cap vs rev $33.0K
GlaxoSmithKline PLC ADR (GSK) versus Senti Biosciences Inc (SNTI) — a side-by-side from cached financials, not a winner call.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Senti Biosciences Inc (SNTI) is a biotechnology company listed on NASDAQ.
GSK does not have a complete income-statement cache yet.
Latest reported SNTI revenue for 2026-06-30 was $33.0K. Net income was -$17.0M. SNTI currently screens at market cap $29.6M.
GSK currently screens at market cap $103.31B and trailing P/E 13.5. SNTI currently screens at market cap $29.6M.
Not investment advice. Open the GSK and SNTI stock pages for the full models.
Not investment advice.